Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	129.79	102.69	110.89	108.01	184.43	143.58
Short-Term Investments	770.58	578.28	292.74	268.39	183.36	171.91
Cash & Short-Term Investments	900.37	680.96	403.63	376.4	367.79	315.49
Cash Growth	106.19%	68.71%	7.23%	2.34%	16.58%	21.95%
Accounts Receivable	9.7	-	-	1.41	10.26	0.85
Other Current Assets	36.85	14.51	12.85	27.49	6.55	6.03
Total Current Assets	946.92	695.47	416.47	405.3	384.6	322.37
Net Property, Plant & Equipment	44	45.26	45.3	58.29	17.35	16.14
Other Intangible Assets	7.29	8.56	10.26	11.96	13.66	15.36
Long-Term Investments	-	-	-	105.87	245.6	137.49
Other Long-Term Assets	1.35	4.48	3.26	0.22	0.27	0.26
Total Assets	1,381	1,140	765.55	691.94	710.15	522.5
Accounts Payable	33.05	11.39	35.87	2.87	9.46	6.83
Accrued Expenses	84.12	85.01	57.73	59.11	23.77	13.45
Short-Term Debt	40	-	-	-	-	-
Current Portion of Leases	7.01	6.34	10.56	2.78	2.25	1.1
Unearned Revenue	22.98	-	0.87	74.1	111.06	19.29
Other Current Liabilities	7.38	0.43	0.44	-	-	0.02
Total Current Liabilities	194.53	103.17	105.46	138.85	146.54	40.68
Long-Term Debt	560.59	734.54	268.33	-	-	-
Long-Term Leases	105.69	111.03	104.61	78.8	23.3	20.04
Other Long-Term Liabilities	-	-	-	55.95	131.5	-
Total Long-Term Liabilities	666.28	845.57	372.93	134.75	154.79	20.04
Total Liabilities	860.81	948.74	478.39	273.6	301.33	60.73
Common Stock	0.23	0.22	0.2	0.2	0.2	0.2
Additional Paid-in Capital	2,120	1,806	1,300	1,219	1,053	965.41
Accumulated Other Comprehensive Income	5.36	4.75	-3.22	-0.14	-0.07	0.02
Retained Earnings	-1,603	-1,626	-1,026	-820.76	-644.69	-503.84
Total Common Shareholders' Equity	522.31	185.44	271.34	398.52	408.82	461.78
Minority Interest	-2.51	5.62	15.82	19.82	-	-
Shareholders' Equity	519.81	191.06	287.16	418.34	408.82	461.78
Total Liabilities & Equity	1,381	1,140	765.55	691.94	710.15	522.5
Total Debt	713.29	851.91	383.5	81.58	25.55	21.14
Net Cash (Debt)	187.09	-170.95	20.13	294.82	342.24	294.36
Net Cash Growth	-	-	-93.17%	-13.86%	16.27%	13.78%
Net Cash Per Share	1.43	-1.43	0.19	2.80	3.30	2.92
Book Value	522.31	185.44	271.34	398.52	408.82	461.78
Book Value Per Share	3.99	1.55	2.54	3.78	3.94	4.58
Tangible Book Value	515.03	176.88	261.08	386.56	395.16	446.42
Tangible Book Value Per Share	3.94	1.48	2.45	3.67	3.81	4.43

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q